Dr. Mautner will study 500 patients over two years. Dr. Mautner believes his study is one of the largest-ever stem cell studies.
“We’re trying to do the right thing. We are trying to move the field forward as well as help patients feel better,” he told Fox 5.
More articles on biologics:
FDA warns Orchid Orthopedics about Michigan facility compliance: 3 details
Reprocessed pedicle screws carry high levels of contamination — 5 insights
42 device company executive moves in 2019
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
